NCT00221871

Unknown

Proper Dosage of Ketamine in Intravenous Regional Anesthesia

University Health Network, Toronto Source

Compare

Other study identifiers

Sponsor study identifier

UHN02-0233-A

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

January 2004

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

January 2005

Date type not reported

This date has not been verified as actual or estimated.

Brief Summary

Ketamine added to Lidocaine can increase duration of pain relief following intraveonous regional anesthesia (IVRA). The purpose of this dose response study is to determine the minimum effective dosage of intravenous Ketamine, added to 3 mg/kg of Lidocaine. We anticipate that one dosage will provide us with the proper balance between sufficient anesthesia and minimal side effects.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Reported enrollment (type unavailable): Not reported
Study completion date: January 2005
Date type not reported
This date has not been verified as actual or estimated.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2004
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
January 2005
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
September 20, 2005
Actual (reported)
First Posted
September 22, 2005
Actual (reported)

Last Updated: October 11, 2006
Status Verified: September 2005
Last Update Submitted: October 10, 2006

Conditions

Pain.

Interventions

Different dosages of KetamineDrug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age: 18-70
Weight: 50-100 kg

Sponsors & Collaborators

University Health Network, Toronto
Otherlead

Study Sites (1)

University Health Network

Toronto, Ontario, M5T2S8, Canada

RECRUITING

Filomena Valle-Leutri, BScCONTACT(416)603-5800 ext. 2016 filomena.valle-leutri@uhn.on.ca

Colin McCartney, MDPRINCIPAL INVESTIGATOR

Vincent Chan, MDSUB INVESTIGATOR

Philip Peng, MDSUB INVESTIGATOR

Paul Tumber, MDSUB INVESTIGATOR

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Colin McCartney, MD
University Health Network, Toronto
PRINCIPAL INVESTIGATOR

Central Study Contacts

Colin McCartney, MD

CONTACT

(416)603-5118 colin.mccartney@uhn.on.ca

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER

Study Record Dates

First Submitted

September 20, 2005

First Posted

September 22, 2005

Study Start

January 2004

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

January 2005

Date type not reported

NCT00465231

Preventive Analgesia in Multiparas Undergoing Induction of Labour

Not ApplicableCompleted

NCT00200876

Effects of Anticipation of Pain Relief on Brain Mechanisms

Not ApplicableCompleted

NCT00293969

A Trial Comparing Different Dosing Regimens of Morphine in Patients With Moderate to Severe Pain

Not ApplicableCompleted

NCT00637533

A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.

Not ApplicableCompleted

NCT00573664

The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section

Not ApplicableTerminated

NCT00456872

Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies

Not ApplicableCompleted

ASA: I, II, III

Carpal tunnel syndrome surgery, tenolysis, ganglion removal or any peripheral hand surgery that can be done by IVRA.

You may not qualify if:

Contraindication to IVRA such as sickle cell disease.
Any known hypersensitivity reaction to Ketamine.
History of chronic pain or regular medication with analgesics.
History of opioid dependence.
Drug of alcohol abuse.
Psychiatric disorder.
Allergy to acetaminophen or codeine

Contact the study team to confirm eligibility.

This date has not been verified as actual or estimated.

Last Updated

October 11, 2006

Record last verified: 2005-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00221871
Data provider: ClinicalTrials.gov
Source updated: 2006-10-11
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:29:34 UTC

Locations

CA(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations